Project Grant 20236701341103
- This Project Grant award of $892,050.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will fund research at the University of Missouri at Kansas City (UMKC) to investigate how plant viruses modulate host chromatin dynamics and gene expression. The key objectives are to: Determine how the PEMV2 virus P26 protein induces chromatin compaction and alters host gene expression, potentially repressing...
- This $836,100 federal Project Grant award from the National Science Foundation's Integrative Activities program (CFDA 47.083) aims to enhance understanding of the genetic mechanisms underlying the bacterial wilt disease that affects cucurbit crops like cucumbers and melons. The key objectives are to screen and characterize disease resistance traits in diverse cucumber and melon populations, and leverage this knowledge to develop sustainable management strategies for this critical agricultural...
- This $3 million National Science Foundation Project Grant under the Biological Sciences federal grant program (CFDA 47.074) will fund research at the University of Illinois exploring the genetic and mechanistic bases of quantitative disease resistance in maize. The research aims to improve understanding of quantitative disease resistance at multiple levels, from genes to tradeoffs at the whole plant level, focusing on some of the most important diseases of corn. A subaward of approximately...
- This Project Grant award from the National Science Foundation's (NSF) Biological Sciences program provides $500,000 from March 2024 through February 2027 to researchers at the University of Maryland and Silvec Biologics, Inc. to develop methods to stabilize RNA genomes in viruses that can be used as therapies to treat plant diseases. The project aims to use computational approaches, including artificial intelligence, to design RNA structures that can be inserted into virus genomes to increase...
- This Project Grant, awarded by the National Science Foundation (NSF) under the Biological Sciences program (CFDA 47.074), aims to develop novel methods for plant genome editing using the parasitic plant Cuscuta campestris (dodder). The $450,000 award, effective July 1, 2024 through June 30, 2027, will enable researchers at the University of Missouri System to: Achieve stable transformation of dodder to enable its use in host gene editing; Develop a dodder protoplast system for rapid screening of...
- This $322,020 Project Grant award from the National Science Foundation's (NSF) Division of Integrative Organismal Systems will support collaborative research at the University of California, Davis (UC Davis) to develop improved methods for CRISPR/Cas9-based gene editing in maize. The key objectives are to generate maize lines expressing high levels of Cas9 nuclease and to engineer and optimize viral vectors to efficiently deliver guide RNAs for both somatic and heritable gene editing. This...
- This $314,560 Project Grant award from the National Science Foundation (NSF) Division of Emerging Frontiers under the Biological Sciences program (CFDA 47.074) supports collaborative research by Purdue University to develop crop varieties that enhance agricultural sustainability. The key objectives are to: Identify genetic targets underlying microbiome-mediated genetic resistance to major current and emergent biotic and abiotic stresses in three widely-grown crops - wheat, tomato, and poplar...
- This Project Grant award from the National Science Foundation's Biological Sciences program (CFDA 47.074) provides $498,983 to Carthage College to develop two biochemical tools to study Potato Virus Y (PVY) infection in plants. The key products to be delivered include: A synthetic PVY viral clone to facilitate the targeted design of chimeric viruses and identify the genetic determinants of PVY infectivity. An enzymatic reporter probe to enable earlier detection of PVY spread within the host...
- This $506,900 project grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) supports research at the University of California, Davis to understand the molecular mechanisms of plant immune response to herbivore-associated peptide elicitors. The three-year award beginning June 1, 2022 will leverage a newly discovered pattern recognition receptor in common beans, INR, to quantify its contribution to overall herbivore defense against caterpillars. Researchers will...
- This $300,000 Project Grant awarded by the National Science Foundation (NSF) under the Biological Sciences program (CFDA 47.074) supports research to develop novel methods for genetically modifying plants using the parasitic plant Cuscuta campestris, also known as dodder. The key goals are to 1) stably transform the dodder plant to enable host gene editing, 2) create a dodder protoplast system for rapid screening of gene editing constructs, and 3) develop a dodder-mediated gene editing system....
** AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** CASSAVA IS AN IMPORTANT CROP FOR SMALL, MEDIUM, AND LARGE-SCALE FARMERS. IT IS A HARDY PLANT THAT CAN BE GROWN WITHOUT IRRIGATION, FERTILIZER OR PESTICIDES AND IS HIGHLY PRODUCTIVE EVEN WHEN GROWN ON MARGINAL LAND. AS SUCH, IT IS LIKELY TO BECOME AN EVEN MORE IMPORTANT CROP IN THE FACE OF GLOBAL CLIMATE CHANGE. CASSAVA MOSAIC DISEASE (CMD) IS A DEVASTATING DISEASE OF CASSAVA ACROSS THE AFRICAN CONTINENT AND HAS RECENTLY SPREAD TO ASIA. SOME VARIETIES OF CASSAVA HAVE NATURAL GENETIC RESISTANCE TO CMD AND THE GENE RESPONSIBLE FOR THIS RESISTANCE WAS RECENTLY IDENTIFIED. HOWEVER, IT IS NOT YET UNDERSTOOD HOW THE RESISTANCE WORKS. WITH HUNDREDS OF MILLIONS OF PEOPLE DEPENDING ON THIS ONE SOURCE OF RESISTANCE TO A DEVASTATING PATHOGEN, A DEEPER UNDERSTANDING OF THE MECHANISM BEHIND THE RESISTANCE IS DESIRED. THIS RESEARCH WILL REVEAL THE MOLECULAR MECHANISMS OF RESISTANCE AND TEST WHETHER THIS TYPE OF RESISTANCE CAN PROTECT DIVERSE AND IMPORTANT CROPS FROM OTHER VIRUS PATHOGENS. IF SUCCESSFUL, THIS RESEARCH WILL LEAD TO SUSTAINABLE AND EFFECTIVE DISEASE CONTROL STRATEGIES FOR MANY IMPORTANT CROPS SUCH AS TOMATO AND COTTON. THROUGHOUT THE RESEARCH, TRAINING WILL BE PROVIDED FOR UNDERGRADUATE AND GRADUATE STUDENTS AND THE IMPORTANCE OF THIS RESEARCH WILL BE SHARED WITH SOCIETY THROUGH A VARIETY OF PUBLIC LECTURES AND OUTREACH EVENTS.CMD IS CAUSED BY SPECIES OF DNA GEMINIVIRUSES. THE CMD RESISTANCE WAS TRACKED TO SPECIFIC AMINO ACID CHANGES WITHIN THE DNA POLYMERASE DELTA SUBUNIT 1 (POLD1) PROTEIN. VIRUSES ARE FANTASTICALLY EFFECTIVE AT OVERCOMING HOST RESISTANCE MECHANISMS AND YET THIS RESISTANCE TRAIT HAS BEEN STABLE FOR DECADES. FURTHER, SEVERAL RESISTANT CULTIVARS OF CASSAVA ARE PERICLINAL CHIMERAS WITH THE RESISTANCE ALLELE PRESENT IN ONLY SPECIFIC CELL LAYERS. WHY THIS RESISTANCE IS SO STABLE AND HOW IT CAN FUNCTION IN THE CONTEXT OF A PERICLINAL CHIMERA, IS NOT YET CLEAR. WHILE SOME OF THE IDENTIFIED POLD1 MUTATIONS ARE NOVEL, OTHERS HAVE BEEN OBSERVED IN YEAST AND RESULT IN DECREASED DNA REPLICATION FIDELITY, POINTING TOWARDS A POSSIBLE FUNCTIONAL MECHANISM. TRANSIENT ASSAYS WILL BE USED TO TEST THIS AND OTHER CANDIDATE MECHANISTIC HYPOTHESES. THESE INCLUDE CHARACTERIZING VIRAL REPLICATION RATES AND FIDELITY OF THE DIFFERENT POLD1 ALLELES, INTERACTION WITH CANDIDATE VIRAL AND HOST CO-FACTORS AND PROTEIN CRYSTALLOGRAPHY. BEYOND CASSAVA, THIS RESEARCH MAY YIELD NEW RESISTANCE STRATEGIES FOR OTHER IMPORTANT CROPS. A RESISTANT POLD1 ALLELE WILL BE TRANSFORMED INTO THE MODEL SYSTEM ARABIDOPSIS, TO DIRECTLY TEST IF THIS RESISTANCE MECHANISM IS EFFECTIVE IN A DISTINCT PATHOSYSTEM. IN ADDITION, EXPLORATION OF PUBLICLY AVAILABLE GENOMIC DATA SUGGESTS THAT SIMILAR ALLELES EXIST IN GERMPLASM COLLECTIONS FROM TOMATO, COTTON, AND SEVERAL OTHER IMPORTANT CROPS.THE RELEVANT GERMPLASM HAS BEEN OBTAINED AND WILL BE CHALLENGED WITH THE RESPECTIVE VIRAL PATHOGENS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | ($370k) | 1/29/26 | ||
| Not listed | $700.0k | 8/23/23 |